Based on the assumption that characterizing the history of a disease will help in improving
practice while offering a clue to research, this article aims at reviewing the history of …

Nonalcoholic fatty liver disease (NAFLD) is a worldwide rising challenge because of hepatic,
but also extrahepatic, complications. Thyroid hormones are master regulators of energy and …

Non-alcoholic fatty liver disease (NAFLD) is a major cause of liver disease worldwide,
affecting up to 30% of adults. Progression to non-alcoholic steatohepatitis (NASH) is a key …

Background & Aims Non-alcoholic fatty liver disease (NAFLD) is a growing public health
problem worldwide and has become an important field of biomedical inquiry. We aimed to …

Simple Summary Non-alcoholic fatty liver disease (NAFLD) is an unmet medical need due to
its increasingly high incidence, severe clinical consequences, and the absence of feasible …

Lifestyle interventions remain the first-line treatment for non-alcoholic fatty liver disease
(NAFLD), even if the optimal alimentary regimen is still controversial. The interest in …

Das Fortschreiten einer NASH ist assoziiert mit Leberzellstress, konsekutiver Entzündung
und Fibrose, mit potentieller Entwicklung einer Leberzirrhose, portaler Hypertension und der …

Western populations are becoming increasingly sedentary and the incidence of
nonalcoholic fatty liver disease (NAFLD) is increasing and becoming one of the most …

Obesity is a complex, multifactorial and chronic disease. Bariatric surgery is a safe and
effective treatment intervention for obesity and obesity-related diseases. However, weight …

Abstract Introduction and Objectives Cardiovascular disease (CVD) is the major cause of
death in non-alcoholic fatty liver disease (NAFLD), a clinical condition without any approved …